LMR Partners LLP Makes New $2.50 Million Investment in BioPlus Acquisition Corp. (NASDAQ:BIOSU)

LMR Partners LLP purchased a new position in BioPlus Acquisition Corp. (NASDAQ:BIOSUGet Rating) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 250,000 shares of the company’s stock, valued at approximately $2,500,000.

A number of other hedge funds and other institutional investors have also modified their holdings of BIOSU. Condor Capital Management bought a new position in BioPlus Acquisition in the 4th quarter worth approximately $32,000. Robinson Capital Management LLC acquired a new stake in shares of BioPlus Acquisition during the 4th quarter worth approximately $163,000. Parallax Volatility Advisers L.P. acquired a new stake in shares of BioPlus Acquisition during the 4th quarter worth approximately $230,000. Landscape Capital Management L.L.C. acquired a new stake in shares of BioPlus Acquisition during the 4th quarter worth approximately $257,000. Finally, Sage Mountain Advisors LLC acquired a new stake in shares of BioPlus Acquisition during the 4th quarter worth approximately $621,000.

Shares of NASDAQ:BIOSU opened at $9.94 on Friday. BioPlus Acquisition Corp. has a 1-year low of $9.92 and a 1-year high of $10.07. The stock’s 50 day moving average price is $10.00.

About BioPlus Acquisition (Get Rating)

BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.

Featured Stories

Want to see what other hedge funds are holding BIOSU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BioPlus Acquisition Corp. (NASDAQ:BIOSUGet Rating).

Institutional Ownership by Quarter for BioPlus Acquisition (NASDAQ:BIOSU)

Receive News & Ratings for BioPlus Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPlus Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.